Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers

BACKGROUND: : Tranexamic acid (TXA) is an antifibrinolytic drug that reduces surgical blood loss and death due to bleeding after trauma and post-partum haemorrhage. Treatment success is dependant on early intervention and rapid systemic exposure to TXA. The requirement for intravenous (IV) administr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kane, Zoe, Picetti, Roberto, Wilby, Alison, Standing, Joseph F., Grassin-Delyle, Stanislas, Roberts, Ian, Shakur-Still, Haleema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science B.V 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299544/
https://www.ncbi.nlm.nih.gov/pubmed/34087356
http://dx.doi.org/10.1016/j.ejps.2021.105893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299544/
https://www.ncbi.nlm.nih.gov/pubmed/34087356
http://dx.doi.org/10.1016/j.ejps.2021.105893

Ejemplares similares